Smith GE - Search Results

1

Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets.

Smith GE, Sun X, Bai Y, Liu YV, Massare MJ, Pearce MB, Belser JA, Maines TR, Creager HM, Glenn GM, Flyer D, Pushko P, Levine MZ, Tumpey TM. Smith GE, et al. Virology. 2017 Sep;509:90-97. doi: 10.1016/j.virol.2017.06.006. Epub 2017 Jun 16. Virology. 2017. PMID: 28624679 Free PMC article.

2

Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice.

Pushko P, Tumpey TM, Bu F, Knell J, Robinson R, Smith G. Pushko P, et al. Vaccine. 2005 Dec 30;23(50):5751-9. doi: 10.1016/j.vaccine.2005.07.098. Epub 2005 Aug 15. Vaccine. 2005. PMID: 16143432

3

Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.

Bright RA, Carter DM, Daniluk S, Toapanta FR, Ahmad A, Gavrilov V, Massare M, Pushko P, Mytle N, Rowe T, Smith G, Ross TM. Bright RA, et al. Vaccine. 2007 May 10;25(19):3871-8. doi: 10.1016/j.vaccine.2007.01.106. Epub 2007 Feb 15. Vaccine. 2007. PMID: 17337102

4

Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza.

Pushko P, Tumpey TM, Van Hoeven N, Belser JA, Robinson R, Nathan M, Smith G, Wright DC, Bright RA. Pushko P, et al. Vaccine. 2007 May 22;25(21):4283-90. doi: 10.1016/j.vaccine.2007.02.059. Epub 2007 Mar 9. Vaccine. 2007. PMID: 17403562

5

Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles.

Wang BZ, Liu W, Kang SM, Alam M, Huang C, Ye L, Sun Y, Li Y, Kothe DL, Pushko P, Dokland T, Haynes BF, Smith G, Hahn BH, Compans RW. Wang BZ, et al. J Virol. 2007 Oct;81(20):10869-78. doi: 10.1128/JVI.00542-07. Epub 2007 Aug 1. J Virol. 2007. PMID: 17670815 Free PMC article.

6

Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle.

Bright RA, Carter DM, Crevar CJ, Toapanta FR, Steckbeck JD, Cole KS, Kumar NM, Pushko P, Smith G, Tumpey TM, Ross TM. Bright RA, et al. PLoS One. 2008 Jan 30;3(1):e1501. doi: 10.1371/journal.pone.0001501. PLoS One. 2008. PMID: 18231588 Free PMC article.

7

Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge.

Perrone LA, Ahmad A, Veguilla V, Lu X, Smith G, Katz JM, Pushko P, Tumpey TM. Perrone LA, et al. J Virol. 2009 Jun;83(11):5726-34. doi: 10.1128/JVI.00207-09. Epub 2009 Mar 25. J Virol. 2009. PMID: 19321609 Free PMC article.

8

Influenza virus-like particles as pandemic vaccines.

Kang SM, Pushko P, Bright RA, Smith G, Compans RW. Kang SM, et al. Curr Top Microbiol Immunol. 2009;333:269-89. doi: 10.1007/978-3-540-92165-3_14. Curr Top Microbiol Immunol. 2009. PMID: 19768411 Review.

9

Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology.

Murawski MR, McGinnes LW, Finberg RW, Kurt-Jones EA, Massare MJ, Smith G, Heaton PM, Fraire AE, Morrison TG. Murawski MR, et al. J Virol. 2010 Jan;84(2):1110-23. doi: 10.1128/JVI.01709-09. Epub 2009 Nov 4. J Virol. 2010. PMID: 19889768 Free PMC article.

10

Recombinant H1N1 virus-like particle vaccine elicits protective immunity in ferrets against the 2009 pandemic H1N1 influenza virus.

Pushko P, Kort T, Nathan M, Pearce MB, Smith G, Tumpey TM. Pushko P, et al. Vaccine. 2010 Jul 5;28(30):4771-6. doi: 10.1016/j.vaccine.2010.04.093. Epub 2010 May 12. Vaccine. 2010. PMID: 20470801

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

643 results

Search Page

Filters